Bristol-Myers Squibb Co (WBO:BMYS) 3-Year Revenue Growth Rate : 4.80% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Bristol-Myers Squibb Co 3-Year Revenue Growth Rate?

Bristol-Myers Squibb Co's Revenue per Share for the three months ended in Sep. 2024 was €5.28.

During the past 12 months, Bristol-Myers Squibb Co's average Revenue per Share Growth Rate was 9.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Bristol-Myers Squibb Co was 14.40% per year. The lowest was -8.40% per year. And the median was 4.40% per year.

Competitive Comparison of Bristol-Myers Squibb Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's 3-Year Revenue Growth Rate falls into.

Bristol-Myers Squibb Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Bristol-Myers Squibb Co (WBO:BMYS) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Bristol-Myers Squibb Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (WBO:BMYS) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMY:Argentina

Address

Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co Headlines

No Headlines